| Serial Number | 85583430 |
| Word Mark | MASE |
| Filing Date | Thursday, March 29, 2012 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, June 17, 2022 |
| Registration Number | 4861676 |
| Registration Date | Tuesday, December 1, 2015 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 21, 2014 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Data and text processing services, namely, the processing of patient specific information, molecular test results and clinical studies data via computer; data collection services for business purposes, namely, the collection and systematic sorting of clinical and patient data, comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection services for business purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments |
| Translation of Words in Mark | The wording "MASE" has no meaning in a foreign language. |
| Goods and Services | Providing an online database featuring diagnostic and therapeutic medical, pharmaceutical and genomic information; providing pharmaceutical information, namely, information about drug safety and drug compatibility in relation to the treatment of individual patients; medical and pharmaceutical consulting services in relation to patient medical treatment options and treatment protocols |
| Goods and Services | Data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data, comprising patient specific molecular and/or genomic data, patient specific clinical data and scientific clinical studies; data collection for research purposes, namely, the collection of mathematic and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to drug treatments; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies; providing medical and scientific research in the fields of pharmaceutical side effects genomics, biological medicine and translational medicine; providing an online database comprised of medical, pharmaceutical, biological and genomic information for scientific research purposes; providing an online searchable database in the fields of medical, pharmaceutical, biological, clinical and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medical, translational medicine, interventional epidemiology, bioinformatics, genomic data and genomic sequence analysis for scientific research purposes; providing online non-downloadable computer software for use by healthcare professionals for medical diagnostic and treatment research; software as a service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical research purposes; design and development of computer software in the fields of biology, medicine and bioinformatics; design and development of computer software for the integration of patient specific data, molecular test results, clinical studies and scientific results; medical and scientific research and scientific consulting services, namely, designing and conducting drug safety and dosage assessment and drug compatibility studies in the field of cancer therapy for others |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, June 17, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, June 17, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, June 17, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | MOLECULAR HEALTH GMBH |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | HEIDELBERG 69115 DE |
| Party Name | MOLECULAR HEALTH GMBH |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | HEIDELBERG 69115 DE |
| Party Name | Molecular Health AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | 4010 Basel CH |
| Party Name | Molecular Health AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | 4010 Basel CH |
| Event Date | Event Description |
| Friday, June 17, 2022 | CANCELLED SEC. 8 (6-YR) |
| Tuesday, December 1, 2020 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, December 1, 2015 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, October 28, 2015 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Friday, September 18, 2015 | NOTICE OF ALLOWANCE CANCELLED |
| Monday, October 19, 2015 | ASSIGNED TO EXAMINER |
| Friday, September 18, 2015 | TEAS DELETE 1(B) BASIS RECEIVED |
| Friday, September 18, 2015 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, September 18, 2015 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, April 23, 2015 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, April 22, 2015 | SOU EXTENSION 2 GRANTED |
| Wednesday, March 18, 2015 | SOU EXTENSION 2 FILED |
| Wednesday, April 22, 2015 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, March 18, 2015 | TEAS EXTENSION RECEIVED |
| Friday, September 19, 2014 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, September 17, 2014 | SOU EXTENSION 1 GRANTED |
| Wednesday, September 17, 2014 | SOU EXTENSION 1 FILED |
| Wednesday, September 17, 2014 | TEAS EXTENSION RECEIVED |
| Wednesday, August 20, 2014 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, March 18, 2014 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 21, 2014 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 21, 2014 | PUBLISHED FOR OPPOSITION |
| Wednesday, January 1, 2014 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 17, 2013 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, December 13, 2013 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, December 13, 2013 | EXAMINER'S AMENDMENT ENTERED |
| Friday, December 13, 2013 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, December 13, 2013 | EXAMINERS AMENDMENT E-MAILED |
| Friday, December 13, 2013 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, October 31, 2013 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Thursday, October 31, 2013 | PRIORITY ACTION E-MAILED |
| Thursday, October 31, 2013 | PRIORITY ACTION WRITTEN |
| Wednesday, October 30, 2013 | DATA MODIFICATION COMPLETED |
| Wednesday, October 2, 2013 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, October 1, 2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 1, 2013 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, September 24, 2013 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, September 26, 2013 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
| Tuesday, March 12, 2013 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, March 12, 2013 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, March 12, 2013 | SUSPENSION LETTER WRITTEN |
| Monday, March 11, 2013 | EXAMINER'S AMENDMENT ENTERED |
| Monday, March 11, 2013 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, March 11, 2013 | EXAMINERS AMENDMENT E-MAILED |
| Monday, March 11, 2013 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, March 5, 2013 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, March 5, 2013 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, March 5, 2013 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, March 5, 2013 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, January 30, 2013 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 30, 2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 22, 2013 | ASSIGNED TO LIE |
| Tuesday, January 22, 2013 | ASSIGNED TO LIE |
| Friday, January 18, 2013 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, January 18, 2013 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, July 20, 2012 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, July 20, 2012 | NON-FINAL ACTION E-MAILED |
| Friday, July 20, 2012 | NON-FINAL ACTION WRITTEN |
| Tuesday, July 10, 2012 | ASSIGNED TO EXAMINER |
| Wednesday, April 4, 2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Monday, April 2, 2012 | NEW APPLICATION ENTERED IN TRAM |